How Product-Centric IT Disrupts Portfolio Management

One of the key functions of Project Portfolio Management (PPM) in IT is that of allocating finite funds to a subset of projects that vie for funding. When it works well, PPM becomes an effective agent of capital allocation within enterprise IT by funding promising projects and terminating underperforming ones. This is not very different to how a venture capitalist might manage their portfolio by investing in promising ventures and freezing funding or writing off investments in ventures that don’t show promise.


Reforming PPM in Traditional Enterprise IT

How do IT portfolio managers know if a project X deserves to be funded over project Y? Traditionally, they have relied on the projections made in project business cases. Those that promise the greatest benefit (or threaten the gravest consequences of not being funded) usually win after a round of scrutiny. Of course, every once in a while, a project is automatically deemed eligible for funding because someone powerful thinks so.

How often are these funding decisions made? At the highest level, they are usually made once a year along with the budgeting cycle. Or they are made as and when projects come up for approval. Additionally, top-up funding decisions are made when a project runs out of funds earlier than planned. However, unlike the case of venture-capital, funding decisions in enterprise IT are rarely made on the basis of actual performance of projects. Funding beyond the first round isn’t based on how well projects are delivering the benefits promised in the project business case. By and large, traditional enterprise IT has been more worried about delivering to plan and less about validating benefits.

Deliver Benefits, Not Scope

As long as the IT development organization is seen as a delivery organization, the responsibility of defining what to deliver rests solely with the business or with the product management organization. Separation of specifications from delivery also hurts the cause of true iterative development and undermines the ability to tweak the product based on learnings from development.

In this scheme of things, IT can’t help but resign itself to attempting to deliver scope on plan. We can talk about benefits validation only when we move to a mode where IT solves problems rather than deliver scope. Benefits are realized when problems are verifiably solved.

The transition, however, from delivering scope to solving problems requires structural change. Typically, IT program and project management organizations worry about delivering scope on plan, while product management (or business) worries about solving problems. These two competencies need to work closer together for the transition to happen. Similar to the merger of development and operations advocated by DevOps we need a merger of product and delivery (ProDel?). Once we have cross-functional teams consisting of product and delivery people, we can turn our attention to the question of how to validate benefits now that we are set up to deliver benefits.

How to Validate Benefits

Nothing validates benefits like sales, one may assert. Not everything we build, however, is market-facing. Even market-facing products may have back-end projects. Besides, sales is also a function of marketing effectiveness, market conditions, and competitors, so it can be misleading to rely exclusively on it. But perhaps the biggest drawback of having to rely on sales feedback is that it is often too late in the day. Iterative product development calls for benefits validation prior to the product/enhancement being generally available for sale.

On the other hand, usage analytics provide a better and generic way of measuring the increase or decrease in uptake after each release. Each release has to be as small as possible in order to get close to the conditions required for a controlled experiment. Frequent, small releases are only possible with Continuous Delivery and so it becomes a prerequisite for institutionalizing the habit of benefits validation.

Analytics are needed to validate benefits whether the product is internal or market-facing. They need to be factored into development efforts just like how performance and other operational requirements are taken into consideration. Most enterprise IT is lacking in this regard and it may take a while to institutionalize analytics. In the meantime, user surveys may serve as a stop-gap technique of benefits validation.

Avoid Single-Stage Funding

Benefits validation is meant to inform subsequent rounds of funding. If benefits aren’t accruing as expected, it may be better to cut losses and divert funds to other projects. However, business cases are sometimes funded at one go. Even if execution is planned as a number of releases, the funds for all releases (meant to realize a business case) is sanctioned at one go. Thus, single-stage funding fails to take advantage of benefits validation.
Avoid Single-Stage Funding
Single-stage funding is sometimes a side-effect of a tedious approval process. Business cases are commonly written to secure 100% funding to avoid cycling through the approval process multiple times. Why are approval processes so tedious? Perhaps because of big project failures in the past or because of the conviction that a strong approval process would increase the chance of success. It has the makings of a vicious circle.

Portfolio Management in Product-Centric IT

The discussion so far has focused on how benefits validation can drive portfolio management in traditional enterprise IT. It called for some changes:

  • Bring product and delivery people to work closer together so as to deliver benefits rather than just deliver scope.
  • Institutionalize the use of production analytics to obtain data for benefits validation.
  • Adopt Continuous Delivery to be able to make frequent, small releases that allow for granular benefits validation.
  • Avoid single-stage funding.

While these changes allow benefits validation-based portfolio management, they don’t reform the basic project-centric execution model of traditional enterprise IT.

Highlights of Product-Centric IT

In addition to the above changes, product-centric IT differs from project-centric IT in the following ways:

  1. We maintain stable teams aligned along business capabilities—no ramp up and down based on projects. These teams own a set of related applications/APIs/services and are responsible for the complete lifecycle (iterative think-it, build-it and run-it). This may require a greater headcount than project-centric IT where we only have teams attending to the most important items in the portfolio backlog. Nevertheless, this increase is more than compensated by increase in team knowledge, responsiveness and effectiveness. Long term custody of a small set of systems also results in lower architectural debt as compared to project-centric mode.
  2. Each business capability area is headed by a capability owner who has a team of product owners each heading a 10 to 15 member product team. For example, an e-commerce platform may include capabilities such as buying and merchandising, catalogue, marketing, customer service, order management, and fulfillment. An insurance business has capabilities such as policy administration, claims administration, and new business. Each capability area is too big to be served by a single team and is therefore organized as a set of sub-capabilities headed by product owners.
  3. Funding for teams rather than projects. More funds allow for bigger teams (or multiple small teams) in a given area of business capability. Funding is changed during annual budgeting cycle based on strategic needs.
  4. Funding is against objectives rather than plans. Capability owners and product owners are accountable for the objectives and have the autonomy to use the funds to prioritize different items on their roadmaps at their discretion.

These aspects of product-centric IT effectively turn the funding part of portfolio management on its head. For the most part, there is no portfolio of projects in product-centric IT. Instead, there is a portfolio of business-aligned capabilities and each such capability is funded once a year in terms of a team capacity budget. The next level of fund allocation is within a capability and is delegated to empowered (and accountable) capability owners and product owners. You don’t need a separate portfolio management function unless we wish to rejig allocations in the middle of the year or fund new capabilities. This degree of churn is only warranted in the experimental portion of an organization’s portfolio. This is the part that benefits from Lean Startup techniques of rapid experimentation and pivoting.

Portfolio Management Across Three Horizons

The three horizons framework offers a way of classifying an organization’s portfolio as stable (H1), emerging (H2) or experimental (H3). Note that this classification is orthogonal to the notions of strategic and business-as-usual (BAU). In most big business (even those that are alerted to the prospect of being disrupted) the experimental part of the portfolio is rarely more than 20% of the pie. This third horizon, as its more experimental, could do with a separate portfolio management function as the business will want to make more smaller, more frequent, and sometimes, opportunistic bets.

The lion’s share of the pie (H1 and H2), on the other hand, when recast as product-centric IT, simply absorbs portfolio management into autonomous line functions (capability owner, product owner). Here is where the rubber meets the road when we speak of arriving at an operating model that allows for autonomy, mastery and purpose on the one hand while balancing for accountability and alignment on the other. In the absence of a separate portfolio management office, capability and product owners have the autonomy to use funds to meet the objectives they are accountable for.

Note that funding controls are still in place. Annual team capacity decisions are strategic allocations made by senior leadership. Capability and product owners have to demonstrate progress (every month or quarter) towards the objectives for which they have been provided with a team. However, since the objectives are now business aligned (rather than being of the nature of delivery to plan), they can be tracked directly by line managers. Traditionally, we have only tracked delivery and so it was okay to have a staff function like portfolio management office look after it.

Not having a separate portfolio management office for H1 and H2 portfolios also makes sense from the point of view of maximizing business-aligned, outcome-oriented teams and minimizing function-aligned, activity-oriented teams. Product-centric IT represents a scaled, outcome-oriented configuration whereas portfolio management is an activity. A separate portfolio management office is a shared service just like how a separate testing team or a separate deployment team is a shared service. Shared services are prone to local optimization and therefore best kept to a minimum.


The habit of benefits validation based portfolio management can be introduced into traditional, project-centric IT. Product-centric IT provides further opportunities to seamlessly embed portfolio management into line management. Institutionalizing benefits validation reforms the funding function of project portfolio management in traditional project-centric IT whereas the move to product-centric IT disrupts (to good effect) the function altogether.

When the measure of success is benefits delivered, portfolio management ceases to be a staff function.
Tweet this